SFFS
ZYME icon

Stonehage Fleming Financial Services’s Zymeworks ZYME Stock Holding History

Stonehage Fleming Financial Services’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-550
Closed -$6.9K – 239
2024
Q3 		$6.9K Hold
550
– – ﹤0.01% 206
2024
Q2 		$4.68K Hold
550
– – ﹤0.01% 215
2024
Q1 		$4.97K Hold
550
– – ﹤0.01% 165
2023
Q4 		$5.71K Hold
550
– – ﹤0.01% 217
2023
Q3 		$3.49K Buy
+550
New +$4.06K ﹤0.01% 237
2023
Q2 		– Sell
-550
Closed -$4.97K – 242
2023
Q1 		$4.97K Hold
550
– – ﹤0.01% 165
2022
Q4 		$4.32K Hold
550
– – ﹤0.01% 165
2022
Q3 		$3K Hold
550
– – ﹤0.01% 188
2022
Q2 		$3K Buy
+550
New +$3.33K ﹤0.01% 247

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Stonehage Fleming Financial Services's ZYME Position: Q4 2024 in Review

Stonehage Fleming Financial Services sold out of Zymeworks (ZYME) in Q4 2024, closing a stake of 550 shares — an estimated $6.9K sold.

Stonehage Fleming Financial Services first reported a position in ZYME in Q2 2022 and held it in 9 quarters. The position peaked at $6.9K in Q3 2024. 172 funds tracked by Wall St. Rank hold ZYME as of Q4 2024.

  • Stonehage Fleming Financial Services reported no remaining Zymeworks position as of Q4 2024 after selling out during the quarter.
  • Stonehage Fleming Financial Services sold 550 Zymeworks shares in Q4 2024, an estimated $6.9K.
  • Stonehage Fleming Financial Services first reported a position in Zymeworks in Q2 2022 and held it in 9 quarters.
  • Stonehage Fleming Financial Services's Zymeworks position peaked at $6.9K in Q3 2024.
  • 172 funds tracked by Wall St. Rank held Zymeworks as of Q4 2024.

Based on Stonehage Fleming Financial Services's 13F filing for Q4 2024, filed 22 Jan 2025.